Moreover, decreasing levels of interferon gamma, interleukin 2, and tumor necrosis factor alpha, as well as the activation of the bradykinin 2 receptor signaling pathway, constitute potential mechanisms underlying the stabilization of atherosclerotic plaques by influenza vaccination (32, 33). The gene discussed is IL2; the disease is influenza.